We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$5.51B
Cap. Flow %
1.92%
Top 10 Hldgs %
12.98%
Holding
8,864
New
807
Increased
4,306
Reduced
2,683
Closed
688

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.31%
2 Technology 9.89%
3 Financials 7.42%
4 Healthcare 6.84%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHIM
7201
DELISTED
Global X MSCI China Materials ETF
CHIM
$12K ﹤0.01%
+703
New +$10.6K
TAT
7202
DELISTED
TransAtlantic Petroleum LTD.
TAT
$12K ﹤0.01%
24,177
+16,681
+223% +$7.59K
VVUS
7203
DELISTED
Vivus Inc
VVUS
$12K ﹤0.01%
4,289
+3,793
+765% +$12.1K
VRML
7204
DELISTED
Vermillion, Inc.
VRML
$12K ﹤0.01%
+14,552
New +$9.58K
AMS icon
7205
American Shared Hospital Services
AMS
$9.58M
$11K ﹤0.01%
4,555
+2,321
+104% +$5.74K
APM
7206
DELISTED
Aptorum Group
APM
$11K ﹤0.01%
71
-81
-53% -$12.6K
ATER icon
7207
Aterian
ATER
$11.9M
$11K ﹤0.01%
152
+6
+4% +$430
BCLI
7208
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$11K ﹤0.01%
167
– –
CCM
7209
Concord Medical Services
CCM
$15.5M
$11K ﹤0.01%
417
+1
+0.2% +$26
COHU icon
7210
Cohu
COHU
$3.14B
$11K ﹤0.01%
496
-78
-14% -$1.4K
DGT icon
7211
State Street SPDR Global Dow ETF
DGT
$711M
$11K ﹤0.01%
121
-327
-73% -$28.2K
DXR icon
7212
Daxor
DXR
$65.4M
$11K ﹤0.01%
+1,155
New +$10.9K
FDEV icon
7213
Fidelity International Multifactor ETF
FDEV
$280M
$11K ﹤0.01%
+406
New +$10.6K
HDG icon
7214
ProShares Hedge Replication ETF
HDG
$22.5M
$11K ﹤0.01%
+240
New +$11K
IMNN icon
7215
Imunon
IMNN
$8.08M
$11K ﹤0.01%
34
+14
+70% +$4.25K
IZEA icon
7216
IZEA Worldwide
IZEA
$44.9M
$11K ﹤0.01%
11,616
+5,704
+96% +$6K
OPLN
7217
PUT
Openlane
OPLN
$4.25B
$11K ﹤0.01%
+500
New +$11.4K
LPRO
7218
DELISTED
Open Lending Corp
LPRO
$11K ﹤0.01%
1,000
– –
MAGA icon
7219
Truth Social America First ETF
MAGA
$30M
$11K ﹤0.01%
369
-1,848
-83% -$52K
MVIS icon
7220
Microvision
MVIS
$47.7M
$11K ﹤0.01%
1,040
+1,014
+3,900% +$11.1K
SDEV
7221
Stablecoin Development Corp
SDEV
$77.4M
$11K ﹤0.01%
+3
New +$11K
NHTC icon
7222
Natural Health Trends
NHTC
$8.02M
$11K ﹤0.01%
2,101
-2,144
-51% -$13.7K
PED icon
7223
PEDEVCO
PED
$176M
$11K ﹤0.01%
+336
New +$9.9K
QDIV icon
7224
Global X S&P 500 Quality Dividend ETF
QDIV
$29.1M
$11K ﹤0.01%
404
-14
-3% -$365
SRS icon
7225
ProShares UltraShort Real Estate
SRS
$16.5M
$11K ﹤0.01%
77
-59
-43% -$9.01K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 807 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.